Santisteban MM, Iadecola C.
2024.
Incompetent neck valves threaten the aging brain.. Nat Aging. 4(10):1346-1347.
Wolujewicz P, Aguiar-Pulido V, Thareja G, Suhre K, Elemento O, Finnell RH, M Ross E.
2024.
Integrative computational analyses implicate regulatory genomic elements contributing to spina bifida.. Genet Med Open. 2:101894.
Knepp B, Navi BB, Rodriguez F, DeAngelis LM, Elkind MSV, Iadecola C, Sherman CP, Tagawa ST, Saxena A, Ocean AJ et al..
2024.
Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.. Ann Neurol. 96(3):565-581.
Knepp B, Navi BB, Rodriguez F, DeAngelis LM, Elkind MSV, Iadecola C, Sherman CP, Tagawa ST, Saxena A, Ocean AJ et al..
2024.
Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.. Ann Neurol. 96(3):565-581.
Knepp B, Navi BB, Rodriguez F, DeAngelis LM, Elkind MSV, Iadecola C, Sherman CP, Tagawa ST, Saxena A, Ocean AJ et al..
2024.
Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.. Ann Neurol. 96(3):565-581.
Knepp B, Navi BB, Rodriguez F, DeAngelis LM, Elkind MSV, Iadecola C, Sherman CP, Tagawa ST, Saxena A, Ocean AJ et al..
2024.
Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.. Ann Neurol. 96(3):565-581.
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SYeni, Li Q et al..
2024.
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.. Cancer Cell. 42(11):1919-1935.e9.
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SYeni, Li Q et al..
2024.
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.. Cancer Cell. 42(11):1919-1935.e9.
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SYeni, Li Q et al..
2024.
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.. Cancer Cell. 42(11):1919-1935.e9.
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SYeni, Li Q et al..
2024.
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.. Cancer Cell. 42(11):1919-1935.e9.